Unicorn Exports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Unicorn Exports Pharmaceutical Export Portfolio Dataset — 2 Products, $59.1K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Unicorn Exports — Pharmaceutical Exporter Profile (2026) | 2 Products, $59.1K Trade | TransData Nexus

Unicorn Exports

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $59.1K Total Trade · DGFT Verified

Unicorn Exports is an Indian pharmaceutical exporter with a total trade value of $59.1K across 2 products in 1 therapeutic categories. Based on 8 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Asava ($41.2K), Kwatha ($17.9K), .

Unicorn Exports — Export Portfolio & Destination Treemap

Unicorn Exports pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Unicorn Exports? — Company Overview & Market Position

Unicorn Exports is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2022, the company is headquartered in Moradabad, Uttar Pradesh, India. The founder and proprietor, Mr. Akash Mohan, holds an MBA from the University of Leeds, UK. The company operates as a private entity, with its Corporate Identification Number (CIN) being U51900MH1990PTC054879. As of the latest available data, Unicorn Exports has reported a total export value of $59,000 USD across 8 shipments, focusing exclusively on Ayurvedic and herbal products. The company's product portfolio is highly concentrated, with its top two products—Asava and Kwatha—accounting for 100% of its exports. The official website is currently under construction, indicating ongoing development of its online presence.

What Does Unicorn Exports Export? — Product Portfolio Analysis

Top Products by Export Value

1Asava$41.2K 2Kwatha$17.9K

Product Portfolio — Top 2 by Export Value

Unicorn Exports exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Asava	Ayurvedic & Herbal Products	$41.2K	5	9.0%	3
2	Kwatha	Ayurvedic & Herbal Products	$17.9K	3	3.3%	10

Unicorn Exports exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $59.1K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Unicorn Exports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Unicorn Exports operates manufacturing facilities in Moradabad, Uttar Pradesh, India. The plant specializes in the production of Ayurvedic and herbal pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding production capacities and certifications are not publicly disclosed, suggesting a focus on maintaining confidentiality and possibly a strategic approach to scaling operations.

3Key Leadership

The leadership of Unicorn Exports is spearheaded by Mr. Akash Mohan, who serves as the Chief Executive Officer (CEO). With an MBA from the University of Leeds, UK, Mr. Mohan brings a blend of academic excellence and practical experience to the company. His strategic vision and leadership are pivotal in steering the company's focus on Ayurvedic and herbal pharmaceutical formulations. Details about other key executives are not publicly available, indicating a centralized leadership structure.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Unicorn Exports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Unicorn Exports' presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly documented. The company's export data from 2022 to 2026 indicates a total export value of $59,000 USD across 8 shipments, focusing exclusively on Ayurvedic and herbal products. This limited export activity suggests that Unicorn Exports may not yet have established a significant footprint in these highly regulated markets. The absence of publicly available regulatory filings or approvals further supports this assessment.

2Emerging Markets

Unicorn Exports has not publicly disclosed its market penetration strategies in emerging markets such as Africa, Latin America, and Southeast Asia. The company's export data indicates a total export value of $59,000 USD across 8 shipments, focusing exclusively on Ayurvedic and herbal products. This limited export activity suggests that Unicorn Exports may not yet have established a significant presence in these regions. The absence of publicly available information regarding WHO prequalification or other certifications necessary for market access in these areas further supports this assessment.

3Geographic Strategy

Unicorn Exports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Unicorn Exports has not publicly disclosed any FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection histories. The company's export data indicates a total export value of $59,000 USD across 8 shipments, focusing exclusively on Ayurvedic and herbal products. This limited export activity suggests that Unicorn Exports may not yet have pursued FDA approvals or registrations, possibly due to the niche nature of its product offerings and the regulatory complexities associated with Ayurvedic and herbal formulations.

2WHO & EU GMP

Unicorn Exports has not publicly disclosed any certifications related to WHO prequalification or EU Good Manufacturing Practice (GMP). The company's export data indicates a total export value of $59,000 USD across 8 shipments, focusing exclusively on Ayurvedic and herbal products. This limited export activity suggests that Unicorn Exports may not yet have pursued these certifications, which are often essential for market access in regulated regions.

3CDSCO & Indian Regulatory

Unicorn Exports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Unicorn Exports operates in the niche market of Ayurvedic and herbal pharmaceutical formulations. While specific competitors are not identified in the available data, the company's focus on a specialized product range suggests that it faces competition from other manufacturers and exporters specializing in Ayurvedic and herbal products. The limited export activity, with a total export value of $59,000 USD across 8 shipments, indicates that Unicorn Exports is in the early stages of establishing its presence in this competitive landscape.

2Key Differentiators

Unicorn Exports' key differentiator lies in its exclusive focus on Ayurvedic and herbal pharmaceutical formulations. By specializing in this niche segment, the company positions itself as a specialist in traditional medicine, catering to a specific market segment that values natural and holistic health solutions. This focus allows Unicorn Exports to develop expertise and potentially offer products with unique formulations and benefits.

3Strategic Position

Unicorn Exports' current strategic direction centers on the production and export of Ayurvedic and herbal pharmaceutical formulations. The company's product portfolio is highly concentrated, with its top two products—Asava and Kwatha—accounting for 100% of its exports. This suggests a deliberate strategy to establish a strong foothold in the niche market of traditional medicine. The future outlook for Unicorn Exports will likely involve expanding its product offerings, pursuing necessary certifications for market access in regulated regions, and scaling operations to meet growing demand.

Buyer Due Diligence Brief — Evaluating Unicorn Exports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Unicorn Exports has demonstrated a consistent track record in exporting Ayurvedic and herbal pharmaceutical formulations, with a total export value of $59,000 USD across 8 shipments. The company's focus on a specialized product range indicates a commitment to quality and consistency. However, the limited export volume suggests that Unicorn Exports is in the early stages of establishing its presence in the international market. Reliability indicators, such as on-time delivery and product quality, are not publicly available, making it challenging to assess the company's performance comprehensively.

2Certifications to Verify

Importers considering partnerships with Unicorn Exports should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm that the products are approved by the U.S. Food and Drug Administration (FDA) for import into the United States. Verification can be done through the FDA's official website or by contacting the FDA directly.

WHO-GMP Certification: Ensure that the manufacturing facilities comply with the World Health Organization's Good Manufacturing Practice (GMP) standards. This can be verified by reviewing the WHO's official list of prequalified manufacturers.

Frequently Asked Questions — Unicorn Exports

How many pharmaceutical products does Unicorn Exports export from India?

Unicorn Exports exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Asava ($41.2K), Kwatha ($17.9K). Total export value is $59.1K.

What is Unicorn Exports's total pharmaceutical export value?

Unicorn Exports's total pharmaceutical export value is $59.1K, based on 8 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Unicorn Exports cover?

Unicorn Exports exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Unicorn Exports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.